HealthLynked (HLYK) EBITDA Margin (2016 - 2025)
Historic EBITDA Margin for HealthLynked (HLYK) over the last 10 years, with Q3 2025 value amounting to 184.41%.
- HealthLynked's EBITDA Margin rose 941300.0% to 184.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 126.19%, marking a year-over-year increase of 220700.0%. This contributed to the annual value of 151.66% for FY2024, which is 812700.0% down from last year.
- According to the latest figures from Q3 2025, HealthLynked's EBITDA Margin is 184.41%, which was up 941300.0% from 110.67% recorded in Q2 2025.
- HealthLynked's EBITDA Margin's 5-year high stood at 175.73% during Q4 2021, with a 5-year trough of 293.09% in Q4 2022.
- In the last 5 years, HealthLynked's EBITDA Margin had a median value of 110.49% in 2022 and averaged 102.89%.
- In the last 5 years, HealthLynked's EBITDA Margin surged by 2395900bps in 2021 and then crashed by -4688200bps in 2022.
- HealthLynked's EBITDA Margin (Quarter) stood at 175.73% in 2021, then plummeted by -267bps to 293.09% in 2022, then surged by 60bps to 116.08% in 2023, then fell by 0bps to 116.38% in 2024, then plummeted by -58bps to 184.41% in 2025.
- Its last three reported values are 184.41% in Q3 2025, 110.67% for Q2 2025, and 116.68% during Q1 2025.